[1] 郭朱明,王顺兰,张诠, 等. 116例牙龈癌的治疗与预后分析 [J]. 癌症, 2008, 27(3): 307-310. [2] 张瑛, 钱忠义, 普苹, 等. VEGF、MMP-9、TIMP-2在口腔颌面部鳞癌中的表达研究 [J]. 口腔医学研究, 2012, 28(11): 1141-1144. [3] 蔡小攀. 口腔鳞癌生物学特点与HIF-1ɑ和VEGF等基因表达的关系 [D].上海: 第二军医大学, 2010. [4] 杨雨晗, 邓缅. PTEN基因调控口腔鳞癌细胞TCA-8113增殖及凋亡 [J]. 第三军医大学学报, 2011, 33(14): 1484-1487. [5] Liu Z, Li L, Yang Z, et al. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma [J]. BMC Cancer, 2010, 10: 270. [6] Jimenez WA, Sardi A, Ledakis P, et al. The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer[J]. Eur J Surg Oncol, 2013, 39(12): 1415-1422. [7] Alyasiri NS, Ali A, Kazim Z, et al. Aberrant promoter methylation of PTEN gene among Indian patients with oral squamous cell carcinoma [J]. Int J Biol Markers, 2013, 28(3): 298-302. [8] Gan YH, Zhang S. PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells [J]. Oral Oncol, 2009, 45(10): e150-154. [9] Goel HL, Chang C, Pursell B, et al. VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer[J]. Cancer Discov, 2012, 2(10): 906-921. [10] Seton-Rogers S. Tumour suppressors: Nuclear PTEN [J]. Nat Rev Cancer, 2013, 13(9): 606. [11] Akiyama-Abe A, Minaguchi T, Nakamura Y, et al. Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas[J]. Br J Cancer, 2013, 109(6): 1703-1710. [12] Price TJ, Hardingham JE, Lee CK, et al. Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab [J]. Cancer Med, 2013, 2(3): 277-285. |